INTRODUCTION
============

Non-typhoidal *Salmonella enterica* serovars (*Salmonella*) are a major cause of bacterial food-borne diseases world-wide ([@B16]). The food poisoning statistics in Japan show that bacterial food poisoning patients during the year 2008 numbered at 10,331 and *Salmonella* were the leading etiological agents accounting for 24.7% of the cases \[<http://idsc.nih.go.jp/iasr/29/342/graph/t3421.gif>\]. Poultry products are important vehicles in the transmission, and have been incriminated in several *Salmonella* outbreaks ([@B14]; [@B8]). Since the late 1990s, *Salmonella enterica* serovar Infantis (*S*. Infantis) has been the commonest serovar of *Salmonella* isolated from both broiler flocks and retail chicken meat in Japan ([@B4]; [@B12]).

The emergence of multidrug-resistant *Salmonella* has become a serious global health problem because antimicrobial treatment is lifesaving for invasive infections, particularly in neonates of \<1 year of age. Preventive antimicrobial treatment is also generally given to patients suffering from immunosuppressive or other predisposing conditions ([@B11]). The options of first-line therapy for *Salmonella* infection include ampicillin (AMP), sulfamethoxazole-trimethoprim, fluoroquinolones, and extended-spectrum cephalosporins (ESCs). ESCs are among the preferred drugs because of resistance to the other aforementioned drugs is relatively frequent in *Salmonella* isolates ([@B11]). At present, ESC-resistance in *Salmonella* is mainly attributed to the acquisition of plasmid-mediated extended-spectrum β-lactamases (ESBLs) and AmpC β-lactamases ([@B6]; [@B1]).

*Salmonella* carrying the *bla*~CMY-2~ gene were recently recovered from bovine and porcine salmonellosis cases ([@B10]; [@B24]). Besides, *S.*Infantis isolates harboring the *bla*~TEM-52~ gene were reported from broilers for the first time in the year 2004 ([@B20]). Thus, a major concern has been increased prevalence of resistance to ESCs noted in *S*. Infantis isolates. This study was conducted to determine the antimicrobial resistance phenotypes and characterize the β-lactamase genes and the plasmids harboring these genes in *S*. Infantis isolated from broiler flocks.

MATERIALS AND METHODS {#s1}
=====================

BACTERIAL ISOLATES
------------------

Between January, 2007 and December, 2008, a total of 1,472 cecal specimens derived from 92 broiler flocks (ca. 10,000 birds per flock) were collected from a poultry processing plant located in the southern part of Japan. Usually, 16 samples per flock were randomly selected fortnightly. The isolation, identification and serotyping of S. Infantis isolates were performed at the Laboratory of Veterinary Public Health, Kagoshima University, Japan as previously described ([@B19]).

DETERMINATION OF MINIMUM INHIBITORY CONCENTRATIONS
--------------------------------------------------

Antimicrobial susceptibility testing was assayed by the agar dilution method on Mueller-Hinton (MH) agar (Oxoid Ltd., Basingstoke, Hampshire, England) plates according to the National Committee for Clinical and Laboratory Standards guidelines ([@B17]). *S*. Infantis isolates were tested for sensitivities to AMP, cefotaxime (CTX), cefoxitin (FOX), chloramphenicol (CHL), streptomycin (STR), sulfamethoxazole (SUL), oxytetracycline (TET), kanamycin (KAN), and ofloxacin (OFX). The MIC range was set at 0.125--512 μg/ml for all tested antimicrobial agents. The MIC breakpoints were interpreted according to the new criteria established by the [@B9]. *Escherichia coli* (*E. coli*) ATCC 25922 and *Staphylococcus aureus* ATCC29213 were used as quality control strains.

DOUBLE-DISK SYNERGY ASSAY
-------------------------

The double-disk synergy testing was conducted to screen for ESBLs and AmpC β-lactamases as previously described ([@B20]). This test was performed as a standard Kirby-Bauer disk diffusion assay on MH agar (Oxoid) plates.

DETECTION OF RESISTANCE DETERMINANTS
------------------------------------

All DNA templates were prepared using the InstaGene Matrix kit (Bio-Rad Laboratories, Hercules, CA, USA). Detection of resistance genes was performed by polymerase chain reaction (PCR). The amplification reactions were carried out using primers and conditions as previously described ([@B10]; [@B21]). Briefly, the targets were as follows: *bla*~TEM~, *bla*~OXA~, *bla*~PSE,~ *bla*~SHV~, *bla*~CTX-M-1~ group, *bla*~CTX-M-2~ group, *bla*~CTX-M-25~, and *Toho-1* encoding for penicillinases; *bla*~CIT~, *bla*~CMY-2~, *bla*~DHA~, *bla*~FOX~, *bla*~MOX~, *bla*~ACC~, and *bla*~EBC~ encoding for cephalosporinases; *tet*(A), *tet*(B), and *tet*(G) mediating tetracycline efflux proteins; *aadA1* and *aadA2* encoding for resistance to STR and spectinomycin; *sul1* conferring resistance to SUL; and *aphA1-Iab* encoding for resistance to KAN.

When β-lactamase-encoding genes were positive following PCR amplification, obtained products were directly sequenced using a BioDye Terminator version 3.1 Ready Reaction sequencing kit and ABI 3100 automated DNA sequencer (Applied Biosystems, Foster City, CA, USA). The DNA alignments and deduced amino acid sequences were examined using the BLAST program (National Center for Biotechnology Information, USA).

PLASMID ANALYSIS
----------------

All *S*. Infantis isolates were examined for the carriage of plasmids by employing the alkaline lysis method as previously described ([@B13]). The molecular size of plasmids was determined by using the standard *Salmonella enterica* serovar Choleraesuis ATCC 7001 (50 kbp) and *S.* Typhimurium DT104 strain 300-98 (90 kbp). The plasmid size was estimated by graphing the molecular size of standard strains versus the distance traveled from the wells using logistic graph paper. Conjugation experiments were performed as described previously ([@B20]). In brief, *S*. Infantis donor isolates and rifampicin-resistant *E. coli* DH5α recipient derivatives were used for conjugal mating. Conjugants were selected onto deoxycholate hydrogen sulfide lactose agar containing 128 μg/ml rifampicin and 128 μg/ml AMP, followed by antimicrobial testing and the detection of transferred resistance genes as above. Plasmids were characterized by the PCR-based replicon typing method as described previously ([@B7]) to detect the plasmid types: IncI1, IncA/C, IncHI1, IncHI2, IncN, IncX, IncW, IncY, IncP, IncT, IncFIIs, IncL/M, IncFIA, IncFIB, IncFIC, IncFrepB, IncK/B, and IncB/O.

RESULTS
=======

ANTIMICROBIAL RESISTANCE
------------------------

*S*. Infantis isolates were recovered in 54 (58.7%) of 92 flocks surveyed and 93 (6.3%) of 1,472 samples examined. Antimicrobial susceptibility profiles of the isolates are summarized in **Table [1](#T1){ref-type="table"}**. Of 93 *S*. Infantis isolates recovered, 34 (36.5%) exhibited resistance to AMP (MIC, 256 to \>512 μg/ml), 33 (35.5%) showed resistance to CTX (MIC, 4-256 μg/ml) and eight (8.6%) demonstrated resistance to FOX (MIC, 32--128 μg/ml). From the 93 isolates and with regard to non-β-lactam antibiotics, 86 (92.5%) isolates exhibited resistance to STR (MIC, 16--512 μg/ml, conferred by *aadA1*), SUL (MIC \>512 μg/ml, conferred by *sul1*) and TET (MIC, 64--512 μg/ml, conferred by*tetA*); 12 (12.9%) isolates showed resistance to KAN (MIC,≥512 μg/ml, conferred by *aphA1*); and 11 (11.8%) isolates demonstrated resistance to OFX (MIC, 2--8 μg/ml). All 93 isolates were fully susceptible to CHL. On the basis of resistance patterns, 11 phenotypes (A to K) were demonstrated as depicted in **Table [2](#T2){ref-type="table"}**. The most frequent pattern was STR/SUL/TET (43 isolates) followed by AMP/CTX/STR/SUL/TET (14 isolates).

###### 

Antimicrobial susceptibility among 93 *Salmonella* Infantis isolates detected in this study.

  Antimicrobial agent   MIC breakpoint (μg/m/)   No. of resistant isolates (%)   
  --------------------- ------------------------ ------------------------------- -----------
  AMP                   ≥32                      34 (36.5)                       29 (24.2)
  CTX                   ≥4                       33 (35.5)                       11 (9.1)
  FOX                   ≥32                      8 (8.6)                         0 (0)
  CHL                   ≥32                      0 (0)                           0 (0)
  STR                   ≥16                      86 (92.5)                       120 (100)
  SUL                   ≥512                     86 (92.5)                       120 (100)
  TET                   ≥16                      86 (92.5)                       120 (100)
  KAN                   ≥64                      12(12.9)                        9 (7.5)
  OFX                   ≥2                       11(11.8)                        25 (20.8)

CTX, cefotaxime; FOX, cefoxitin; CHL, chloramphenicol; STR, streptomycin; SUL, sulfamethoxazole; TET, oxytetracycline; KAN, kanamycin; OFX, ofloxacin. (a) Cited from the previous study (

Shahada et al., 2010b

)

###### 

Distribution of resistance phenotypes, plasmid profiles and β-lactamase phenotypes in *Salmonella* Infantis isolates.

  Resistance pattern   Resistance phenotype          Plasmid   No. of isolates   β-lactamase phenotype            
  -------------------- ----------------------------- --------- ----------------- --------------------------- ---- ------
  A                    AMP/CTX/FOX/STR/SUL/TET/KAN   I         180               IncP                        1    AmpC
  B                    AMP/CTX/FOX/STR/SUL/TET       I         180               IncP                        7    AmpC
  C                    AMP/CTX/STR/SUL/TET/OFX       II        180, 50           IncP, Non-typable           4    ESBL
  D                    AMP/CTX/STR/SUL/TET/KAN       II        180,50            IncP, Non-typable           2    ESBL
  E                    AMP/CTX/STR/SUL/TET           I         180               IncP                        2    ESBL
                       AMP/CTX/STR/SUL/TET           II        180, 50           IncP, Non-typable           11   ESBL
                       AMP/CTX/STR/SUL/TET           III       180, 125, 50      IncP, IncA/C, Non-typable   1    ESBL
  F                    AMP/CTX                       II        180, 50           IncP, Non-typable           5    ESBL
  G                    AMP/STR/SUL/TET               I         180               IncP                        1    \-
  H                    STR/SUL/TET/OFX               I         180               IncP                        7    \-
  I                    STR/SUL/TET/KAN               I         180               IncP                        7    \-
  J                    STR/SUL/TET                   I         180               IncP                        43   \-
  K                    KAN                           I         180               IncP                        2    --

AMP, ampicillin; CTX, cefotaxime; FOX, cefoxitin; CHL, chloramphenicol; STR, streptomycin; SUL, sulfamethoxazole; TET, oxytetracycline; KAN, kanamycin; OFX, ofloxacin

.

ESBL AND AMPC CHARACTERIZATION
------------------------------

Double-disk synergy testing revealed 25 ESBL- and eight AmpC β-lactamase-producing*S*. Infantis isolates. TEM-type ESBL was identified in 23 (24.7%) isolates, CTX-M-type ESBL was demonstrated in one isolate and CMY-type AmpC β-lactamase was detected in eight isolates. Nucleotide sequencing of PCR products confirmed that the amplicons were *bla*~TEM-52~ (22 isolates), *bla*~TEM-20~ (one isolate), *bla*~CTX-25~ (one isolate in combination with *bla*~TEM-52~), and *bla*~CMY-2~ (8 isolates). Of 54 S. Infantis-positive flocks, As indicated in **Table [3](#T3){ref-type="table"}**, *S*. Infantis isolates harboring *bla*~TEM-1~ were not detected during the present study; but, they were found during 1998--2003 (one isolate) and 2004--2006 (17 isolates). On the other hand, isolates harboring *bla*~TEM-52~ were identified during 2004--2006 (11 isolates) and 2007--2008 (22 isolates). Isolates carrying the *bla*~TEM-20~, *bla*~CTX-25,~ and *bla*~CMY-2~ genes were demonstrated during 2007--2008 study period.

###### 

Chronological change of β-lactamase genes in serovar Infantis.

  β-lactamase gene *(bla)*   No. of isolates during the isolation period                
  -------------------------- --------------------------------------------- ------------ ---------------------------------------
  TEM-1                      1 (0.7%)                                      17 (14.2%)   0 (0%)
  TEM-52                     0 (0%)                                        11 (9.2)     22 (24.4%)^[d](#fn04){ref-type="fn"}^
  TEM-20                     0 (0%)                                        0 (0%)       1 (1.8%)
  CTX-M-25                   0 (0%)                                        0 (0%)       1 (1.8%)
  CMY-2                      0 (0%)                                        0 (0%)       8 (8.6%)

Cited from the previous study ([@B18]).

Cited from the previous study ([@B21]).

This study.

CTX-M-25 and TEM-52 were simultaneously identified in one isolate.

PLASMID CHARACTERIZATION
------------------------

Three plasmid profiles were defined among *S*. Infantis isolates. Seventy isolates harbored ca. 180-kbp plasmids (profile I), 22 isolates carried two plasmids of ca. 50 and 180 kbp (profile II), and one isolate possessed three plasmids of ca. 50, 125, and 180 kbp (profile III; **Figure [1](#F1){ref-type="fig"}**). Isolates exhibiting resistance to ESCs displayed diverse profiles: Of 34 ESC-resistant*S*. Infantis isolates, 22 belonged to profile II, 11 were classified into profile I and one isolate was categorized into profile III (**Table [2](#T2){ref-type="table"}**). PCR-based replicon typing revealed three kinds of plasmids. Large-size plasmids (ca.180 kbp) were typed as IncP, intermediate-size plasmid (ca. 125 kbp) was typed as IncA/C and small plasmids (ca. 50 kbp) were non-typable. Large-, intermediate- and small-size plasmids were self-transmissible to *E. coli* recipient strain by conjugation. The *bla*~TEM-20~ and *bla*~CMY-2~ genes were associated with large IncP plasmids, *bla*~CTX-M-25~ was affiliated with intermediate IncA/C plasmid and the *bla*~TEM-52~ gene was linked to small non-typable plasmids.

![**Three plasmid profiles obtained from *S.* Infantis isolates**. Lane M1 and M2 shows standard sizes of plasmids extracted from *S. Choleraesuis* ATCC 7001 (50 kbp) and *S*. Typhimurium DT104 strain 300-98 (90 kbp), respectively. L1: IncP (ca. 180 kbp), L2: IncP (ca. 180 kbp) and Untypable plasmid (ca. 50 kbp), L3: IncP (ca. 180 kbp), IncA/C (ca. 125 kbp), and Untypable plasmid (ca. 50 kbp).](fmicb-04-00113-g001){#F1}

DISCUSSION
==========

The results obtained in this study show that resistance to ESCs has increased to 35.5% from the previous 9.2% reported during an earlier investigation ([@B21]). Other new findings include the detection of *S.*Infantis isolates harboring the *bla*~TEM-20~, *bla*~CTX-M-25,~ and *bla*~CMY-2~ genes. Demonstration of these resistance traits in *S*. Infantis serovar is a rare phenomenon. This is the first report describing these mechanisms of ESC-resistance exhibited by *S*. Infantis isolates derived from broilers. Previous reports indicate that β-lactam resistance in broilers was once mediated by *bla*~TEM-1~, a narrow-spectrum β-lactamase gene that was demonstrated in one *S*. Infantis isolate recovered during 1998--2003 ([@B18]) and 14.2% of the isolates obtained in 2004--2006 ([@B20]). Besides, during the period of 2004--2006, resistance to ESCs mediated by *bla*~TEM-52~ was reported for the first time from the broiler industry in Japan ([@B20]).

In the present study, we identified one *S*. Infantis isolate harboring the *bla*~TEM-20~ gene while other isolates had *bla*~TEM-52~. It's worth noting that the wild-type *bla*~TEM-1~ gene was not detected during this study suggesting the likelihood of occurrence of point mutations which led to the emergence of observed variants, *bla*~TEM-20~ and *bla*~TEM-52~. This hypothesis is supported by deduced amino acid sequence analysis which revealed that the *bla*~TEM-20~ gene differs from *bla*~TEM-1~ by two substitutions, Met182→Thr and Gly238→Ser; whereas the *bla*~TEM-52~ gene differs from *bla*~TEM-1~ by three substitutions, Glu104 Lys, Met182→Thr, and Gly238→Ser ([@B2]; [@B25]). This phenomenon has the implications for bacterial adaptation mechanism because *bla*~TEM-1~ seems to have lost its fitness as a potential resistance trait necessary for survival of *Salmonella*. Thus, point mutations have taken place as the evolutionary adaptation mechanism crucial for successful colonization of the broiler chicken intestinal tract.

In Japan, CTX-M-type ESBL-producing *Enterobacteriaceae* are important nosocomial infectious agents raising considerable concern in the public health community. Similarly, the detection of CTX-M-2 and CTX-M-25 ESBL-producing *E. coli* isolates from chickens affected with colibacillosis has raised concerns in the veterinary public health community ([@B15]; [@B5]). We report for the first time one *S*. Infantis isolate harboring *bla*~CTX-M-25~ on IncA/C plasmid and *bla*~TEM-52~ on non-typable plasmid. Because *bla*~CTX-M-25~ was initially demonstrated in *E. coli*([@B5]) a comprehensive molecular study is required to determine the likely source and elucidate mechanisms involved in collecting antimicrobial resistance traits and mobilizing them across taxonomical borders.

To date, several reports have described the emergence of AmpC β-lactamase-producing *Salmonella* derived from farm animals affected with salmonellosis. One of the studies involving*Salmonella* *enterica* serovar Typhimurium (*S*. Typhimurium) identified *bla*~CMY-2~ associated with self-transmissible IncI1-Iγ and A/C plasmids ([@B24]). Another study revealed a novel chromosomally integrated multi-drug resistance genomic island harboring *bla*~CMY-2~ among clonally related *S*. Typhimurium isolates ([@B22]). Consequently, the detection of *bla*~CMY-2~ in several *S*. Infantis isolates from broilers poses another challenge in the veterinary public health community. Carriers of *bla*~CMY-2~ harbored IncP plasmids initially demonstrated in *Pseudomonas* bacteria ([@B23]).

Antimicrobial susceptibility data indicate a gradual decrease of OFX resistance to 11.8 from 20.8% previously reported ([@B21]). Fluoroquinolones (e.g., OFX) are broad-spectrum antimicrobial agents widely used in clinical medicine. Emergence of fluoroquinolone resistance was attributed to overuse of this group of drugs in domestic animals either therapeutically or for the purpose of growth promotion ([@B3]). Since 1991, the Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) approved this class of antimicrobials in veterinary medicine for therapeutic purposes and prohibited its use as feed additives. Fluoroquinolones might have been prescribed prudently among antimicrobial agents used in broiler farms in Japan. This likely has contributed to the decline of resistance to OFX observed in the present study.

Taken together, these results show increased resistance against ESCs mediated by both ESBLs and AmpC β-lactamases. It seems these resistance traits have spread among farm animals in Japan while their likely source remains largely unknown. The probability that resistance to ESCs may continue to spread among members of the *Enterobacteriaceae* family poses another public health challenge because ESBLs and AmpC β-lactamases limit the effectiveness of cephalosporin therapy.
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